Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, People's Republic of China.
Department of Radiology, Xi'an Daxing Hospital, Xi'an, People's Republic of China.
Eur Arch Psychiatry Clin Neurosci. 2024 Mar;274(2):433-443. doi: 10.1007/s00406-023-01626-6. Epub 2023 Jul 3.
Dopamine receptor D2 (DRD2) TaqIA polymorphism has an influence on addiction treatment response and prognosis by mediating brain dopaminergic system efficacy. Insula is crucial for conscious urges to take drugs and maintain drug use. However, it remains unclear about the contribution of DRD2 TaqIA polymorphism to the regulation of insular on addiction behavioral and its relation with the therapeutic effect of methadone maintenance treatment (MMT).
57 male former heroin dependents receiving stable MMT and 49 matched male healthy controls (HC) were enrolled. Salivary genotyping for DRD2 TaqA1 and A2 alleles, brain resting-state functional MRI scan and a 24-month follow-up for collecting illegal-drug-use information was conducted and followed by clustering of functional connectivity (FC) patterns of HC insula, insula subregion parcellation of MMT patients, comparing the whole brain FC maps between the A1 carriers and non-carriers and analyzing the correlation between the genotype-related FC of insula sub-regions with the retention time in MMT patients by Cox regression.
Two insula subregions were identified: the anterior insula (AI) and the posterior insula (PI) subregion. The A1 carriers had a reduced FC between the left AI and the right dorsolateral prefrontal cortex (dlPFC) relative to no carriers. And this reduced FC was a poor prognostic factor for the retention time in MMT patients.
DRD2 TaqIA polymorphism affects the retention time in heroin-dependent individuals under MMT by mediating the functional connectivity strength between left AI and right dlPFC, and the two brain regions are promising therapeutic targets for individualized treatment.
多巴胺受体 D2(DRD2)TaqIA 多态性通过调节大脑多巴胺能系统的效能,对成瘾治疗反应和预后产生影响。脑岛对于有意识的药物渴求和维持药物使用至关重要。然而,DRD2 TaqIA 多态性对成瘾行为的脑岛调节作用及其与美沙酮维持治疗(MMT)疗效的关系尚不清楚。
纳入 57 名接受稳定 MMT 的男性前海洛因依赖者和 49 名匹配的男性健康对照者(HC)。进行唾液 DRD2 TaqA1 和 A2 等位基因基因分型、脑静息态功能磁共振成像扫描以及 24 个月的非法药物使用信息采集,并对 HC 脑岛的功能连接(FC)模式进行聚类,对 MMT 患者的脑岛亚区进行分割,比较 A1 携带者和非携带者之间的全脑 FC 图,并通过 Cox 回归分析脑岛亚区与 MMT 患者保留时间相关的基因型相关 FC 之间的相关性。
确定了两个脑岛亚区:前脑岛(AI)和后脑岛(PI)亚区。与非携带者相比,A1 携带者的左侧 AI 与右侧背外侧前额叶皮质(dlPFC)之间的 FC 降低。并且这种降低的 FC 是 MMT 患者保留时间的不良预后因素。
DRD2 TaqIA 多态性通过调节左侧 AI 与右侧 dlPFC 之间的功能连接强度,影响 MMT 下海洛因依赖个体的保留时间,这两个脑区是个体化治疗的有前途的治疗靶点。